Why the study?
Does immunoadsorption improve LVEF and reduce nt-BNP and nt-ANP plasma levels in patients with severe heart failure due to dilated cardiomyopathy?
Does immunoadsorption improve LVEF and reduce nt-BNP and nt-ANP plasma levels in patients with severe heart failure due to dilated cardiomyopathy?
Immunoadsorption in patients with severe heart failure due to dilated cardiomyopathy improves left ventricular function and reduces nt-BNP and nt-ANP plasma levels.
No takes yet. Share an insight, caveat, or question.
Supports further study of immunoadsorption in dilated cardiomyopathy; hypothesis-generating and should not change practice yet.
Staudt et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: